Neuroprotection by Cell Permeable TAT-mGluR1 Peptide in Ischemia: Synergy between Carrier and Cargo Sequences

Abstract

Overactivation of glutamate receptors is a critical mechanism for neuronal death in ischemic stroke. Previously, we reported that overactivation of N-methyl-D-aspartate (NMDA)—type glutamate receptor induced calpain-mediated truncation of metabotropic glutamate receptor mGluR1α, resulting in suppression of its neuroprotective signaling pathway. A fusion peptide containing the transactivating regulatory protein (TAT) protein transduction domain (PTD) and the mGluR1α sequence spanning the calpain cleavage site effectively blocked mGluR1α truncation and protected neurons against NMDA-induced neuronal toxicity. We recently evaluated the role of this mechanism in ischemia-induced cell death. We found that mGluR1α was truncated in both in vitro and in vivo models of stroke and that this truncation was accompanied by the typical calpain-mediated proteolysis of spectrin. The TAT-mGluR1 fusion peptide produced robust neuroprotective effect in the in vitro model of stroke. In addition, we found that the TAT protein transduction domain peptide itself altered the function of membrane channels through some unknown mechanisms and showed some mild neuroprotective effects. Together, these experiments indicated a synergistic relationship between the TAT carrier sequence and the mGluR1α peptide cargo sequence, and this synergy might account for the neuroprotective properties of the TAT-mGluR1 peptide. NEUROSCIENTIST 14(5):409—414, 2008. DOI: 10.1177/1073858407309762

Keywords

NMDA receptor Calpain Metabotropic glutamate receptor Stroke Neuroprotection

Get full access to this article

View all access options for this article.

References

Aarts M. , Liu Y. , Liu L. , Besshoh S. , Arundine M. , Gurd JW , and others. 2002. Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions. Science 298:846-50.

Adhami F. , Liao G. , Morozov YM , Schloemer A. , Schmithorst VJ , Lorenz JN , and others. 2006. Cerebral ischemia-hypoxia induces intravascular coagulation and autophagy. Am J Pathol 169:566-83.

Asoh S. , Ohsawa I. , Mori T. , Katsura K. , Hiraide T. , Katayama Y. , and others. 2002. Protection against ischemic brain injury by protein therapeutics. Proc Natl Acad Sci U S A 99:17107-12.

Batchelor AM , Garthwaite J. 1997. Frequency detection and temporally dispersed synaptic signal association through a metabotropic glutamate receptor pathway. Nature 385:74-7.

Bi X. , Chang V. , Siman R. , Tocco G. , Baudry M. 1996. Regional distribution and time-course of calpain activation following kainateinduced seizure activity in adult rat brain. Brain Res 726:98-108.

Borsello T. , Clarke PG , Hirt L. , Vercelli A. , Repici M. , Schorderet DF, and others. 2003. A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia. Nat Med 9:1180-6.

Calò L. , Bruno V. , Spinsanti P. , Molinari G. , Korkhov V. , Esposito Z. , and others. 2005. Interactions between ephrin-B and metabotropic glutamate 1 receptors in brain tissue and cultured neurons. J Neurosci 25:2245-54.

Crocker SJ , Smith PD , Jackson-Lewis V. , Lamba WR , Hayley SP , Grimm E., and others. 2003. Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease. J Neurosci 23:4081-91.

Glading A. , Bodnar RJ , Reynolds IJ , Shiraha H. , Satish L. , Potter DA , and others. 2004. Epidermal growth factor activates m-calpain (calpain II), at least in part, by extracellular signal-regulated kinase-mediated phosphorylation. Mol Cell Biol 24:2499-512.

10.

Goll DE , Thompson VF , Li H. , Wei W. , Cong J. 2003. The calpain system. Physiol Rev 83:731-801.

11.

Hara MR , Snyder SH 2007. Cell signaling and neuronal death. Annu Rev Pharmacol Toxicol 47:117-41.

12.

Hong SC , Lanzino G. , Goto Y. , Kang SK , Schottler F. , Kassell NF , and others 1994. Calcium-activated proteolysis in rat neocortex induced by transient focal ischemia. Brain Res 661:43-50.

13.

Joliot A. 2005. Transduction peptides within naturally occurring proteins . Sci STKE 2005:pe54.

14.

Kilic U. , Kilic E. , Dietz GP , Bahr M. 2003. Intravenous TAT-GDNF is protective after focal cerebral ischemia in mice. Stroke 34:1304-10.

15.

Lai Y. , Du L. , Dunsmore KE , Jenkins LW , Wong HR , Clark RS 2005. Selectively increasing inducible heat shock protein 70 via TAT-protein transduction protects neurons from nitrosative stress and excitotoxicity. J Neurochem 94:360-6.

16.

Lee MS , Kwon YT , Li M. , Peng J. , Friedlander RM , Tsai LH 2000. Neurotoxicity induces cleavage of p35 to p25 by calpain . Nature 405:360-4.

17.

Lujan R. , Nusser Z. , Roberts JD , Shigemoto R. , Somogyi P. 1996. Perisynaptic location of metabotropic glutamate receptors mGluR1 and mGluR5 on dendrites and dendritic spines in the rat hippocampus . Eur J Neurosci 8:1488-500.

18.

Page G. , Khidir FA , Pain S. , Barrier L. , Fauconneau B. , Guillard O. , and others. 2006. Group I metabotropic glutamate receptors activate the p70S6 kinase via both mammalian target of rapamycin (mTOR) and extracellular signal-regulated kinase (ERK 1/2) signaling pathways in rat striatal and hippocampal synaptoneurosomes. Neurochem Int 49:413-21.

19.

Pei DS , Wang XT , Liu Y. , Sun YF , Guan QH , Wang W. , and others. 2006. Neuroprotection against ischaemic brain injury by a GluR6-9c peptide containing the TAT protein transduction sequence . Brain 129(Pt 2): 465-79.

20.

Pellegrini-Giampietro DE 2003. The distinct role of mGlu1 receptors in post-ischemic neuronal death. Trends Pharmacol Sci 24:461-70.

21.

Rodríguez-Moreno A. , Sistiaga A. , Lerma J. , Sanchez-Prieto J. 1998. Switch from facilitation to inhibition of excitatory synaptic transmission by group I mGluR desensitization. Neuron 21:1477-86.

22.

Rong R. , Ahn JY , Huang H. , Nagata E. , Kalman D. , Kapp JA , and others. 2003. PI3 kinase enhancer-Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis. Nat Neurosci 6: 1153-61.

23.

Schröder UH , Opitz T. , Jager T. , Sabelhaus CF , Breder J. , Reymann KG 1999. Protective effect of group I metabotropic glutamate receptor activation against hypoxic/hypoglycemic injury in rat hippocampal slices: timing and involvement of protein kinase C. Neuropharmacology 38: 209-16.

24.

Tateyama M. , Kubo Y. 2006. Dual signaling is differentially activated by different active states of the metabotropic glutamate receptor 1alpha. Proc Natl Acad Sci U S A 103:1124-8.

25.

Thandi S. , Blank JL , Challiss RA 2002. Group-I metabotropic glutamate receptors, mGlu1a and mGlu5a, couple to extracellular signal-regulated kinase (ERK) activation via distinct, but overlapping, signalling pathways. J Neurochem 83:1139-53.

26.

Thompson RJ , Zhou N. , MacVicar BA 2006. Ischemia opens neuronal gap junction hemichannels . Science 312:924-7.

27.

Wadia JS , Stan RV , Dowdy SF 2004. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med 10:310-5.

28.

Xiong ZG , Zhu XM , Chu XP , Minami M. , Hey J. , Wei WL, and others. 2004. Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels. Cell 118:687-98.

29.

Xu W. , Wong TP , Chery N. , Gaertner T. , Wang YT , Baudry M. 2007. Calpain-mediated mGluR1alpha truncation: a key step in excitotoxicity. Neuron 53:399-412.